- Home
- GFUZ vs THW Comparison
GFUZ vs THW Comparison
Compare GFUZ & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | GFUZ | THW |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Finance Companies |
| Sector | Utilities | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 687.0M | 565.9M |
| IPO Year | 2025 | 2015 |
Fundamental Metrics
Financial Performance| Metric | GFUZ | THW |
|---|---|---|
| Price | $7.71 | $13.95 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 180.8K | 116.1K |
| Earning Date | N/A | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.08 | $11.18 |
| 52 Week High | $11.00 | $14.50 |
Technical Indicators
Market Signals| Indicator | GFUZ | THW |
|---|---|---|
| Relative Strength Index (RSI) | 49.30 | 53.64 |
| Support Level | $6.08 | $12.33 |
| Resistance Level | $10.03 | $14.50 |
| Average True Range (ATR) | 0.71 | 0.23 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 43.31 | 13.85 |
Price Performance
Historical ComparisonAbout GFUZ General Fusion Group Ltd. Common Shares
General Fusion Group Ltd is focused on developing fusion energy technology based on Magnetized Target Fusion (MTF), which combines magnetic confinement and mechanical compression to achieve fusion conditions. It operates a large-scale demonstration system, Lawson Machine 26 (LM26), intended to validate elements of its technology and support the development of commercial fusion power plants for electricity generation.
About THW abrdn World Healthcare Fund Shares of Beneficial Interest
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.